Author： Zesiewicz T.A. Hauser R.A.
Publisher： Adis International
ISSN： 1172-7047
Source： CNS Drugs, Vol.17, Iss.8, 2003-01, pp. : 593-600
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Dopamine Agonists in Parkinsons Disease: What is Their Role in Early Treatment?
By Stocchi F.
CNS Drugs, Vol. 10, Iss. 3, 1998-09 ,pp. :
Access to resources
Recommend
Dopamine agonists in Parkinson’s disease
By Tintner Ron Jankovic Joseph
Expert Opinion on Investigational Drugs, Vol. 12, Iss. 11, 2003-11 ,pp. :
Treatment of Parkinsons Disease: Whats on the Horizon?
By Wu Stacy S.
CNS Drugs, Vol. 19, Iss. 9, 2005-01 ,pp. :
Are Dopamine Receptor Agonists Neuroprotective in Parkinson's Disease?
Drugs & Aging, Vol. 18, Iss. 6, 2001-06 ,pp. :
Dopamine agonists cost effective for cotherapy of Parkinson's disease?
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 332, 2001-01 ,pp. :